Articles should focus on the full range and scope of unit operations and production steps for manufacturing APIs, both small molecule and biologic pharmaceuticals, the building and critical process utility systems that support the manufacturing process, as well as the means of managing, dynamically controlling, and automating manufacturing and warehousing operations. Articles could highlight production unit operations, management, and control.

Molecular Attributes
Sponsored Content
Molecular Attributes
Resins, Monoliths, or Membranes? Discover How to Make an Educated Choice.
ZETA
Sponsored Content
From Upstream to Downstream: Solutions for the Entire Process
As a pioneer in aseptic processing solutions, ZETA focuses on the design, construction, automation, and qualification of customized biopharmaceutical plants, using fully integrated digital engineering tools - all the way to the digital twin. Many years of experience and an outstanding ability to...
Figure 4
Technical
Safeguarding Vial Container Closure Integrity: A Systematic Approach
Any systematic pharmaceutical engineering approach for ensuring vial container closure system (CCS) performance must include choosing qualified container closure system components, the proper pharmaceutical process setup, and applicable testing methods. Container closure integrity (CCI) is an...
Molecular Attributes
Sponsored Content
Molecular Attributes
Resins, Monoliths, or Membranes? Discover How to Make an Educated Choice.
ZETA
Sponsored Content
From Upstream to Downstream: Solutions for the Entire Process
As a pioneer in aseptic processing solutions, ZETA focuses on the design, construction, automation, and qualification of customized biopharmaceutical plants, using fully integrated digital engineering tools - all the way to the digital twin. Many years of experience and an outstanding ability to...
Figure 4
Technical
Safeguarding Vial Container Closure Integrity: A Systematic Approach
Any systematic pharmaceutical engineering approach for ensuring vial container closure system (CCS) performance must include choosing qualified container closure system components, the proper pharmaceutical process setup, and applicable testing methods. Container closure integrity (CCI) is an...
Applying Robotic Process Automation in the Pharma Industry
Online Exclusives
Applying Robotic Process Automation in the Pharma Industry
Robotic process automation (RPA) software automatically handles manual, repetitive, time-consuming, and highly structured tasks such as data entry and back-office functions. Certain processes specific to the pharmaceutical industry represent strong candidates for RPA implementation, with...
Article
Technical
Justifying Investment in Manufacturing Execution Systems
Executives at manufacturing companies of all sizes need to make decisions about where to invest to maintain and grow their businesses. Investments in manufacturing execution system (MES) applications may reduce costs and increase revenues, but they also might compete with other investment...
Using CFD Multiphase Modeling to Predict Bioreactor Performance
Technical
Using CFD Multiphase Modeling to Predict Bioreactor Performance
Computational fluid dynamics (CFD) can reduce or eliminate the need to perform bioreactor scale-up studies because full-scale manufacturing bioreactors can be simulated to predict performance. This article discusses the use of computational fluid dynamics for that purpose, to predict the...
Quality & Regulatory Solutions for PAT in Continuous Manufacturing
Technical
Quality & Regulatory Solutions for PAT in Continuous Manufacturing
Process analytical technology (PAT) is perceived as the main enabler for a robust control strategy with continuous manufacturing (CM) because process analytical technology can aid in implementing continuous manufacturing throughout the entire life cycle. This article discusses quality and...
A Gamp® Approach to Robotic Process Automation
Features
A GAMP® Approach to Robotic Process Automation
This article introduces the concept of robotic process automation (RPA) and discusses how the technology may be used within a GAMP® framework to support both non-GxP and GxP processes.
Article
Technical
Purification Of Synthetic Peptides
High-pressure liquid chromatography employing the multicolumn countercurrent solvent gradient purification (MCSGP) process principle has been developed as a novel purification technology for peptides produced by chemical synthesis. MCSGP offers a step change in efficiency compared to batch...
Article
Technical
Evaluating In-line Volume Reduction During mAb Production
In-line concentration solves problems found in mAb production, including insufficient storage capacity and process tank volumes, extended processing times, and large hold-up loop volumes for ultrafiltration concentration. It optimizes the ion-exchange step following capture, reduces costs and...
Article
Technical
Statistical Approach for CU Testing CPV Batches & Comparison with USP <905> UDU
The USP &lt;905&gt; UDU test, widely used for batch release since 2007, is no longer supported by FDA. We propose a two-sided tolerance interval method to alleviate this deficiency. The approach provides 50% confidence and 95% probability that future samples from the batch will conform to USP...